ID24861A - THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION - Google Patents

THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION

Info

Publication number
ID24861A
ID24861A IDP20000134D ID20000134D ID24861A ID 24861 A ID24861 A ID 24861A ID P20000134 D IDP20000134 D ID P20000134D ID 20000134 D ID20000134 D ID 20000134D ID 24861 A ID24861 A ID 24861A
Authority
ID
Indonesia
Prior art keywords
street
make
growth hormone
hormone secretion
secretion
Prior art date
Application number
IDP20000134D
Other languages
Indonesian (id)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24861A publication Critical patent/ID24861A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDP20000134D 1999-02-26 2000-02-24 THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION ID24861A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
ID24861A true ID24861A (en) 2000-08-31

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000134D ID24861A (en) 1999-02-26 2000-02-24 THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION

Country Status (43)

Country Link
US (2) US6541634B2 (en)
EP (2) EP1449842A1 (en)
JP (3) JP3437813B2 (en)
KR (2) KR100372063B1 (en)
CN (3) CN1515570A (en)
AP (1) AP1221A (en)
AR (2) AR029617A1 (en)
AT (1) ATE277944T1 (en)
AU (1) AU764122B2 (en)
BG (1) BG104175A (en)
BR (2) BRPI0000967B8 (en)
CA (1) CA2299495C (en)
CO (1) CO5160252A1 (en)
DE (1) DE60014212T2 (en)
DK (1) DK1031575T3 (en)
DZ (1) DZ3018A1 (en)
EA (1) EA003218B1 (en)
EE (1) EE200000193A (en)
ES (1) ES2226712T3 (en)
GT (1) GT200000018A (en)
HN (1) HN2000000021A (en)
HR (1) HRP20000103A2 (en)
HU (1) HUP0000907A3 (en)
ID (1) ID24861A (en)
IL (2) IL157103A (en)
IN (1) IN192352B (en)
IS (1) IS5380A (en)
MA (1) MA25072A1 (en)
NO (1) NO20000965L (en)
NZ (1) NZ503062A (en)
OA (1) OA11325A (en)
PA (1) PA8491201A1 (en)
PE (1) PE20001550A1 (en)
PL (1) PL338628A1 (en)
PT (1) PT1031575E (en)
SG (1) SG90096A1 (en)
SI (1) SI1031575T1 (en)
SK (1) SK284982B6 (en)
TN (1) TNSN00035A1 (en)
TR (1) TR200000536A2 (en)
TW (2) TW200718702A (en)
UA (1) UA70306C2 (en)
ZA (1) ZA200000888B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
WO2001091752A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
US9499543B2 (en) * 2013-05-28 2016-11-22 Raqualia Pharma Inc. Polymorph forms
CN109320515A (en) * 2018-11-22 2019-02-12 常州大学 A kind of asymmetric synthesis method of Capromorelin chiral intermediate
CN120265641A (en) * 2023-04-21 2025-07-04 长春金赛药业有限责任公司 GHSR 1a agonist, pharmaceutical composition, preparation method and application thereof
CN119285632A (en) * 2024-10-09 2025-01-10 威海中腾医药科技有限公司 A method for preparing a caprelin intermediate based on yeast alcohol dehydrogenase-catalyzed oxidation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
SK56296A3 (en) 1993-11-09 1997-02-05 Merck & Co Inc Piperidinal, pyrrolidinal and hexahydro-1h-azepinal derivatives, manufacturing process thereof and pharmaceutical compositions containing them
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA53716C2 (en) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. A substituted dipeptide tartaric salt as an agent stimulating the growth hormone secretion
UA64751C2 (en) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Treatment of insulin tolerance using substances increasing growth hormone secretion
DE69837264T2 (en) 1997-06-25 2008-01-31 Pfizer Inc. Dipeptide compounds that are growth hormone secretagogues

Also Published As

Publication number Publication date
CN1837205A (en) 2006-09-27
SG90096A1 (en) 2002-07-23
NO20000965D0 (en) 2000-02-25
AP2000001754A0 (en) 2000-03-31
BRPI0000967B1 (en) 2012-06-12
EP1031575A1 (en) 2000-08-30
AP1221A (en) 2003-11-03
KR100361783B1 (en) 2002-11-22
AU1947100A (en) 2000-08-31
HN2000000021A (en) 2001-02-02
JP2000247974A (en) 2000-09-12
CA2299495C (en) 2010-06-15
IL157103A (en) 2007-07-24
IN192352B (en) 2004-04-10
KR100372063B1 (en) 2003-02-14
BRPI0017522B1 (en) 2013-09-24
AR029617A1 (en) 2003-07-10
JP3437813B2 (en) 2003-08-18
CN1515570A (en) 2004-07-28
US6673929B2 (en) 2004-01-06
SI1031575T1 (en) 2005-02-28
ES2226712T3 (en) 2005-04-01
HU0000907D0 (en) 2000-04-28
IS5380A (en) 2000-08-27
HK1030219A1 (en) 2001-04-27
CN1137891C (en) 2004-02-11
PA8491201A1 (en) 2001-04-30
IL134599A0 (en) 2001-04-30
TWI286142B (en) 2007-09-01
BG104175A (en) 2000-12-29
IL134599A (en) 2006-12-10
DK1031575T3 (en) 2005-01-03
DE60014212D1 (en) 2004-11-04
ZA200000888B (en) 2001-08-23
DZ3018A1 (en) 2004-03-20
EE200000193A (en) 2000-10-16
EP1031575B1 (en) 2004-09-29
HRP20000103A2 (en) 2001-04-30
TW200718702A (en) 2007-05-16
SK2302000A3 (en) 2000-11-07
JP2003327585A (en) 2003-11-19
EA200000172A2 (en) 2000-08-28
MA25072A1 (en) 2000-10-01
PL338628A1 (en) 2000-08-28
BRPI0017522B8 (en) 2021-05-25
UA70306C2 (en) 2004-10-15
US6541634B2 (en) 2003-04-01
SK284982B6 (en) 2006-03-02
JP4051314B2 (en) 2008-02-20
AU764122B2 (en) 2003-08-07
CA2299495A1 (en) 2000-08-26
BRPI0017522A2 (en) 2009-12-22
PE20001550A1 (en) 2001-01-11
EA003218B1 (en) 2003-02-27
BRPI0000967A (en) 2001-09-11
PT1031575E (en) 2004-11-30
JP2003261565A (en) 2003-09-19
HUP0000907A3 (en) 2001-05-28
IL157103A0 (en) 2004-02-08
HUP0000907A2 (en) 2001-03-28
TNSN00035A1 (en) 2005-11-10
KR20020065455A (en) 2002-08-13
GT200000018A (en) 2001-08-16
DE60014212T2 (en) 2005-12-15
EA200000172A3 (en) 2000-10-30
AR053722A2 (en) 2007-05-16
ATE277944T1 (en) 2004-10-15
TR200000536A2 (en) 2000-09-21
CO5160252A1 (en) 2002-05-30
BRPI0000967B8 (en) 2021-12-07
US20020002283A1 (en) 2002-01-03
EP1449842A1 (en) 2004-08-25
US20030158414A1 (en) 2003-08-21
NZ503062A (en) 2001-07-27
OA11325A (en) 2003-10-27
NO20000965L (en) 2000-08-28
CN1270960A (en) 2000-10-25
KR20010006698A (en) 2001-01-26

Similar Documents

Publication Publication Date Title
ATE310728T1 (en) TETRAHYDROISOCHINOLINE ANALOGUE AS GROWTH HORMONE SECRETAGOGEN
GB2349273B (en) Method of making photovoltaic device
ID27013A (en) THE PROCESS TO MAKE A PIECE OF POWDER FOR MAKING GLASS
EE200100649A (en) A-beta peptide compositions and methods for their preparation
ATE362472T1 (en) GROWTH HORMONE SECRETION PROMOTERS
ID26441A (en) PROCESS TO PRODUCE ANHYDRIDAL FTALATES
NO20000823L (en) A means to promote secretion of growth hormone
PT1150966E (en) METHOD OF PREPARATION OF 5-CYANOFOHALIDE
EP1210046A4 (en) Enhanced wound coverage to enhance wound healing
ID23963A (en) THE PROCESS OF MAKING VINIL ACETATE
PT1240157E (en) SUBSTITUTED DERIVATIVES OF N-BENZYL-INDOL-3-IL-GLIOXALIC ACID WITH ANTITUMORAL EFFECT
ID24861A (en) THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION
AR025582A1 (en) SIMILAR POLYPEPTIDES TO THE FIBROBLASTO GROWTH FACTOR
ATE375996T1 (en) SECRETION PROMOTERS FOR GROWTH HORMONE
EP1158996A4 (en) NEW AMID DERIVATIVES AS GROWTH HORMONE SECRETION CONVEYORS
TW419029U (en) Structure improvement of sliding-sleeve tyep waterproof night lamp
DE60039965D1 (en) COMPOSITION FOR THE ACQUISITION OF IMMUNOLOGICAL TOLERANCE
DE69927048D1 (en) IBANDROINIC ACID TO PROMOTE OSSEOINTEGRATION OF ENDOPROTHESIS
PT1228056E (en) METHOD OF PREPARING CITALOPRAME
EE200200253A (en) Method for the preparation of conjugated linolenic acid
FI972968L (en) Methods to prevent growth hormone effects
NO20021234D0 (en) Use of thienopyrimidines
TW394354U (en) Betterment for structure of night lamp
FR2802802B1 (en) SPLIT FOR LOWER LIMBS OF THE POSTERIOR GUTTER TYPE
NO20022671D0 (en) Process for the preparation of thienopyrimidines